Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China: Duloxetine Versus Placebo

NCT01179672 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01179672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01179672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China: Duloxetine Versus Placebo
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
August 31, 2013
Enrollment
405 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful